For the year ending 2025-12-31, IIPR had -$98,648K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income | 118,247 |
| Depreciation and amortization | 74,068 |
| Impairment loss on real estate | 3,527 |
| Loss (gain) on exchange of exchangeable senior notes | 0 |
| Loss (gain) on sale of real estate | -326 |
| Other non-cash adjustments | 275 |
| Paid-in-kind dividends and interest income on life science investments | 826 |
| Stock-based compensation | 10,132 |
| Amortization of discounts on investments | 0 |
| Amortization of debt discount and issuance costs | 1,999 |
| Other assets, net | 1,286 |
| Accounts payable, accrued expenses and other liabilities | -854 |
| Rent received in advance and tenant security deposits | -6,869 |
| Net cash provided by (used in) operating activities | 198,189 |
| Investments in real estate | 7,857 |
| Investments in life science financial instruments | 150,251 |
| Proceeds from sale of real estate assets | 2,239 |
| Funding of draws for improvements and construction | 23,432 |
| Funding of construction loan and other investments | 0 |
| Purchases of short-term investments | 5,258 |
| Maturities of short-term investments | 10,258 |
| Net cash provided by (used in) investing activities | -174,301 |
| Issuance of common stock, net of issuance costs | 0 |
| Repurchase of common stock | 20,108 |
| Issuance of preferred stock, net of issuance costs | 24,148 |
| Draws on revolving credit facilities | 155,000 |
| Repayments on revolving credit facilities | 52,500 |
| Principal payment on debt | 8,697 |
| Payment of deferred financing costs | 0 |
| Dividends paid to common stockholders | 216,275 |
| Dividends paid to preferred stockholders | 3,240 |
| Taxes paid related to net share settlement of equity awards | 864 |
| Net cash provided by (used in) financing activities | -122,536 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -98,648 |
| Cash, cash equivalents and restricted cash, beginning of year | 146,245 |
| Cash, cash equivalents and restricted cash, end of year | 47,597 |
INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR)
INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR)